Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide and orotic acid for Polyoma BK viruria in kidney transplant
NCT01620268Phase 2Terminated
- Sponsor
- Suzhou Changzheng Cinkate Pharmaceutical Co., Ltd.
- Start
- Jul 2012
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leflunomide, orotic acid in BK virus infection, sponsored by Suzhou Changzheng Cinkate Pharmaceutical Co., Ltd.. Started Jul 2012; status: terminated.
02
Drugs
leflunomideorotic acid
03
Conditions
BK virus infection
Beyond the preview
Go deeper on NCT01620268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01620268.